Company / Assets per Share
Apellis Pharmaceuticals, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$8.64
FY2025
5-year range
$7.12 / $11.58
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#112 of 210
Health Care
What the data says
At $8.64, Apellis Pharmaceuticals, Inc.'s assets per share ranks #112 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $3.25 in FY2016 to $15.02 in FY2020.
Based on SEC 10-K filings.
8.64 in FY2025 with a 5-year CAGR of -10.5%.
Improved from $7.12 to $8.64 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- -10.5%
- 10-Year CAGR
- -
Sector benchmark
#112 of 210 in Health CareTop 53% of 210This company $8.64 Sector average $353.15
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 16.7% year-over-year.
- Ranks #112 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.64 | +16.7% |
| FY2024 | $7.40 | +4.0% |
| FY2023 | $7.12 | -8.7% |
| FY2022 | $7.80 | -32.7% |
| FY2021 | $11.58 | -22.9% |
| FY2020 | $15.02 | +140.2% |
| FY2019 | $6.26 | +67.2% |
| FY2018 | $3.74 | -71.5% |
| FY2017 | $13.13 | +303.4% |
| FY2016 | $3.25 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026